Are you designing novel modifications or using a variety of design approaches for specific transfection?

If you can also share the size of the oligos I may be able to suggest a few sequence tweaks to consider to avoid common performance issues. Cholesterol to nanotechology, variations to targeting...

01 January 1970 5,323 0 View